Philippe Boucheron - Integragen Director, representing CDC Entreprises
| ALINT Stock | EUR 0.64 0.01 1.54% |
Director
Mr. Philippe Boucheron serves as Director at Integragen SA, representing CDC Entreprises. He is also Investment Director at Bioam, a biotechnology investment fund. From 1993 to 1996, Mr. Boucheron worked at BioCapital LP, one of Canadas VC funds focusing on biotechnology. From 1997 to 2000, he directed the equity research team at the Paris office of ING Barings Ferri
| Phone | 33 1 60 91 09 00 |
| Web | https://integragen.com |
Integragen Management Efficiency
The company has return on total asset (ROA) of 0.0149 % which means that it generated a profit of $0.0149 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1498 %, meaning that it generated $0.1498 on every $100 dollars invested by stockholders. Integragen's management efficiency ratios could be used to measure how well Integragen manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 1 records | DIRECTOR Age | ||
| Nicolas Poirier | OSE Pharma SA | 41 | |
Management Performance
| Return On Equity | 0.15 | |||
| Return On Asset | 0.0149 |
Integragen Leadership Team
Elected by the shareholders, the Integragen's board of directors comprises two types of representatives: Integragen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Integragen. The board's role is to monitor Integragen's management team and ensure that shareholders' interests are well served. Integragen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Integragen's outside directors are responsible for providing unbiased perspectives on the board's policies.
| MBA DVM, CEO Director | ||
| Joerg Leenings, Head Centre | ||
| JeanPol Detiffe, Chief Director | ||
| Francois Liebaert, Vice President - Research & Development and Medical Affairs | ||
| Emmanuel Martin, Director Sales & Marketing for the Services Business Unit | ||
| Gerald Wagner, Director | ||
| Brengre Gnin, Research Academics | ||
| Laurence Lamotte, Director of Administration and Finance | ||
| Anne Philippi, CoFounder Epidemiology | ||
| Benoit Adelus, Director | ||
| Bernard Courtieu, Chairman of the Board, Chief Executive Officer | ||
| Philippe Boucheron, Director, representing CDC Entreprises | ||
| Francis Rousseau, Director of Genomics | ||
| Chantal Parpex, Director, representing CDC Innovation | ||
| Louis Nisbet, Director, representing Kurma Life Sciences Partners | ||
| Pierre Flamant, Adm Director | ||
| Cyril Harfouche, Director | ||
| Larry Yost, Chief Executive Officer - Integragen Inc |
Integragen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Integragen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.15 | |||
| Return On Asset | 0.0149 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.02 % | |||
| Current Valuation | 5.39 M | |||
| Shares Outstanding | 6.6 M | |||
| Shares Owned By Insiders | 65.89 % | |||
| Price To Earning | 44.59 X | |||
| Price To Book | 3.91 X | |||
| Price To Sales | 0.63 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Integragen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Complementary Tools for Integragen Stock analysis
When running Integragen's price analysis, check to measure Integragen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integragen is operating at the current time. Most of Integragen's value examination focuses on studying past and present price action to predict the probability of Integragen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integragen's price. Additionally, you may evaluate how the addition of Integragen to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |